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With Parkinson’s disease, there is quite a bit of research going into it. And not all of it
goes as planned or passes the test of time as much as we would hope it to be. As we remember
with the scientific method that was drilled into us since we started learning science in the first
place, even after the data analysis stage shows that something does a specific thing, we are to
keep testing it to add more data to it. And this is one of those examples of where new data with
new experiments shows that something in the past is now incomplete with its findings. The
specific issue is that the mechanisms with the Vitamin B3 derivative “Nicotinamide” its
“mechanism of action is complex and not specific for therapeutic effectiveness in Parkinson’s
disease.” (Melão, A.)
The long version is a bit more interesting. To start with Nicotinamide is a Vitamin B3
derivative that comes in many protein filled foods like beef, pork, peanuts and mushrooms as
some examples. In a normal cell, it is a precursor to NAD+, which is commonly used in energy
mechanisms in the cell. With regards to what it was thought to do with Parkinson’s disease is
that it would help the formation of the mitochondria in the cell, helping with energy supplies, and
treatment would help resist motor function loss in a “fly model” (Melão, A.) of the disease. Now
however the story is that it causes the nerve cells to degenerate even faster and it made the
disease exacerbate disease manifestations in mice. They experimented by basically giving a lot
of mice the disease and then giving them the Nicotinamide. What they found though, is that it

epigenetically increased the amount of neuroprotective gene expression that should help to
protect the nerves, but caused the opposite effect as the proteins were not produced from them
for a so far unknown reason. The study also said at the end as a foot note that it may also be the
animal model being different than before that caused this change and that further testing should
be done.
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